Showing 71-80 of 3024 results for "".
Detecting Multiple Sclerosis Earlier: PRLs and the Evolving McDonald Diagnostic Criteria
https://practicalneurology.com/diseases-diagnoses/ms-immune-disorders/detecting-multiple-sclerosis-earlier-prls-and-the-evolving-mcdonald-diagnostic-criteria/54390/This episode explores new evidence showing that paramagnetic rim lesions (PRLs) are highly prevalent early in multiple sclerosis (MS) and can differentiate MS from mimics with striking accuracy. Daniel Ontaneda, MD, PhD, Cleveland Clinic Lerner College of Medicine, Cleveland, OH, and Pascal Sati, PhOptic Neuritis: Update on Diagnosis, Management, and Long-term Follow-up
https://practicalneurology.com/columns/practice-management/PN1009_02-php/30879/Specialists share insights on diagnostic tools, prospects for neuroprotective therapies, and the risk of MS.A Treatment Within
https://practicalneurology.com/diseases-diagnoses/ms-immune-disorders/a-treatment-within/30713/A small Phase I trial sees success using patients' own altered blood cells to fight immune responses in MS. Is this the future of MS therapy?An Overview of Neuropsychiatric Symptoms, Clinical Features, and Management Options for Individuals Living with Multiple Sclerosis
https://practicalneurology.com/archives/aug-2025-issue/an-overview-of-neuropsychiatric-symptoms-clinical-features-and-management-options-for-individuals-living-with-multiple-sclerosis/36690/Recognizing psychiatric manifestations, understanding their origin, and providing proper treatment are imperative to comprehensive care of people living with MS.Clinical Neuroinflammatory Mimics of Multiple Sclerosis
https://practicalneurology.com/diseases-diagnoses/ms-immune-disorders/clinical-neuroinflammatory-mimics-of-multiple-sclerosis/54599/NMOSD, MOGAD, and MS have overlapping clinical presentations but are distinct inflammatory CNS diseases, each with their own established diagnostic criteria.Therapeutics Q&A:
https://practicalneurology.com/diseases-diagnoses/ms-immune-disorders/therapeutics-qa/30861/The first drug approved specifically to manage a symptom of MS is shown to improve patients' walking ability.Ocrelizumab and the Next Phase in Multiple Sclerosis Therapy
https://practicalneurology.com/diseases-diagnoses/ms-immune-disorders/ocrelizumab-and-the-next-phase-in-multiple-sclerosis-therapy/30505/Advances in immune therapy may change how scientists and clinicians understand neurodegenerative components of MS.Multiple Sclerosis--Is it One Disease or Many Diseases?
https://practicalneurology.com/diseases-diagnoses/ms-immune-disorders/multiple-sclerosis-is-it-one-disease-or-many-diseases/30103/Dr. Stephen Krieger will share his view that MS is one disease state while Dr. Bianca Weinstock-Guttman challenges that view, arguing that MS is many disease states.Diagnostic Q&A: Optical Coherence Tomography and Multiple Sclerosis
https://practicalneurology.com/diseases-diagnoses/ms-immune-disorders/diagnostic-qa-using-optical-coherence-tomography-to-diagnose-multiple-sclerosis/30823/New findings suggest a novel in-office imaging technique can help identify MS patients who are likely to have increased disease severity. An investigator explains.Pediatric-Onset Multiple Sclerosis
https://practicalneurology.com/diseases-diagnoses/ms-immune-disorders/pediatric-onset-multiple-sclerosis/30128/Information from clinical trials in children with MS is furthering understanding and improving treatment options for this rare presentation.